Back
Delegates Premium Access

Semaglutide and dapagliflozin synergistically prevent cancer therapy-related cardiac dysfunction in hyperglycemic conditions

Session: Cardiovascular protection in patients with cancer
Topic: Cardio-Oncology
Speaker: Doctor V. Quagliariello (Naples, IT)
Event: ESC Preventive Cardiology 2025

Congress Presentation

Add to my library

Like

About the speaker

Doctor Vincenzo Quagliariello

National Cancer Institute G.Pascale Foundation IRCCS, Naples (Italy)
0 follower

2 more presentations in this session

PSA - a potential biomarker for the intersection of screening for cardiovascular disease and cancer

Speaker: Ms E. Unger (Hamburg, DE)

Access
Abstract
Slides
Like
Thumbnail

Cardioprotective effects of prophylactic ACE Inhibitors in anthracycline-based chemotherapy: a systematic review and meta-analysis

Speaker: Mr D. Pizzi (Milano, IT)

Access
Abstract
Slides
Like
Thumbnail

Access the full session

Cardiovascular protection in patients with cancer

Speakers: Doctor V. Quagliariello, Ms E. Unger, Mr D. Pizzi
Access
Like
Thumbnail

About the event

Image

ESC Preventive Cardiology 2025

3 April - 5 April 2025

Sessions Presentations

Congress
logo Image

ESC 365 is supported by

logo Bristol Myers Squibb Explore sponsored resources
logo Novo Nordisk Explore sponsored resources